Member Info for ForFXSake

They were probably all scared off by the boardroom massacre of early 2020.

It looks like Thillai is no longer associated with us after founding Qureight (which is where Gooding works now). It's all a bit 'jobs for the boys' in biopharma. Everyone seems to either shift around all the time or have multiple roles. There appear to be very few who seem loyal to one organisation. Thankfully, Joanne and Alex appear to be wholly committed to NFX.

Yep. That's what I've been saying all along and that's why the board flogging off discounted placing shares to pump n dumpers is going to keep us where we are until something major drops.

It's very quiet this morning, not a single trade so far.

I think all the twitter peeps are busy emailing Walbrook with their questions:

Are those sellers out?
Will this multibag?
News tomorrow?
Who is Fred Gawn?

:0)

Sorry for the multiple posts this AM, I'm a little bored. I might go and download Minesweeper now.

Do you think one of the bitter exes put him on there and then changed the password so they couldn't take him off?

As far as posts go, I think you should be our 3rd CEO.

The job is way too big for Anne and Frederick Gawn (who still appears to be there on LinkedIn)

You should strongly consider it Soup, board-membership here would only be a part-time role, after all.

To be honest, the various pump and dump crews chasing their 2% are probably doing more to hold the price back than those two sellers (if they are indeed still selling).

The volume in recent weeks has been way beyond the volume held by those two individuals.

Keep moaning!!

According to Swazers, NFX and it's channel are now in an uptrend.

Nothing like a bit of upside-Dow Theory.

I'll tell you tomorrow

https://www.oxilio.co.uk/clinical-trials

They seem to be confident enough to openly mention hopes for OXL001 on their website. Not sure how old this is but I don't recall seeing it before and thought it worthy of a link.

Apologies if you've already seen it.

I think the cap on royalties is only considered to be too low if we don't receive the significant upfront payment we were originally promised.

If the terms have changed (for the worse) with regards to what we get in the near term then why should we not expect more in the long term. That is only fair.

If we get a significant upfront and/or milestones then, personally, I have no problem with the cap. I would rather have the money available now, when we need it most.

I really cannot see them hiring a PR firm in the face of a failing Oxilio deal. It just doesn't add up.

Why would you go ahead with an expense like that if it has to come out the placing money that was already ear-marked for NXP002 testing? It would be madness!!

I think it's a pump-initiation buy. You can see a trickle of smaller buys following.
We'll probably see the same amount dumped come 2.4p

28k trade (1 million) just gone through.

Nice to see a buy for a change

I don't think the board will listen. They need their fundraisers ;0)

They must be planning some kind of handover.

It doesn't make make financial sense to hire both an external contractor for Investor Relations plus a PR company...especially if you have nothing really to say.

Either things are going to start moving on the newsfront soon or they are gearing up to sell more discounted shares into the P&D sausage machine. I did hear it right in that Walbrook specialise in non-institutional private investors?

I'm guessing Fleur has left then?

There's always that filter Robbo

https://uk.advfn.com/stock-market/london/nuformix-NFX/share-news/Nuformix-PLC-Appointment-of-Dr-Karl-Keegan/81777696